Latest Injection Stories
The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection FRANKLIN LAKES, N.J., Aug.
On July 30, the FDA published that one lot of Lidocaine HCI Injection, USP, 2%, by Hospira is recalled due to visible particulates.
The cannula technique, now offered at Ethos Spa Skin Care and Laser Centers, provides a much gentler approach to administering skin rejuvenating fillers than the traditional sharp beveled hypodermal
LONDON, July 17, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
On July 11, the FDA informed that one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, by Hospira Inc., is recalled due to mold contamination.
GIA announces the release of a comprehensive global report on Syringes (Disposable & Reusable) markets.
GIA announces the release of a comprehensive global report on Special Purpose Needles markets.
Transparency Market Research published a new report "Safety Syringes Market: Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2013 - 2019" to its report store.
ALBANY, New York, June 24, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Safety Syringes Market [http://www.marketresearchreports.biz/analysis-details/retractable-safety-syringes-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The industry has experienced steady growth over the past five years; over the next five years, an aging and increasingly obese US population will continue to provide steady demand for industry